成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Wuhan Jingkangen Biomedical Technology Co., Ltd

Wuhan Jingkangen Biomedical Technology Co., Ltd

Current Location: HOME >> Product
Product Categories
Country: China
Tel: 13720134139 +86 -0-15871494362
Mobile: 13720134139
E-mail:
QQ:
Skype: Chat Now!
Product Name MF CAS Details
C188-9 C27H21NO5S 432001-19-9 Details
Oxybutynin chloride C22H32ClNO3 1508-65-2 Details
Reltecimod C46H72N10O15S 1447799-33-8 Details
DS-3201 C26H34ClN3O4 1809336-39-7 Details
Atomoxetine HCL C17H22ClNO 82248-59-7 Details
5-Aza-2'-deoxycytidine C8H12N4O4 2353-33-5 Details
ABT 263 C47H55ClF3N5O6S3 923564-51-6 Details
Research Grade Bamlanivimab (DVV00303) 2423943-37-5 Details
Pyrotinib dimaleate C40H39ClN6O11 1397922-61-0 Details
GLP-1 C186H275N51O59 87805-34-3 Details
Sabatolimab 2252262-24-9 Details
orellanine C10H8N2O6 37338-80-0 Details
Ravulizumab 1803171-55-2 Details
MRTX-1257 C33H39N7O2 2206736-04-9 Details
MRTX 9768 C24H17FN6O 2629314-68-5 Details
BMS-986177 C28H23Cl2F2N9O2 1802425-99-5 Details
Remibrutinib C27H27F2N5O3 1787294-07-8 Details
Melatonine C13H16N2O2 73-31-4 Details
Ondansetron hydrochloride C18H22ClN3O2 103639-04-9 Details
AG-270 C18H24ClN3O3 13299-99-5 Details
Magrolimab 2169232-81-7 Details
MRTX0902 C22H24N6O 2654743-22-1 Details
Adagrasib C32H35ClFN7O2 2326521-71-3 Details
Research Grade Anti-Human CD152 Details
Research Grade Acazicolcept 2270247-50-0 Details
Glumetinib C21H17N9O2S 1642581-63-2 Details
Research Grade Anti-Human CD19 Details
OUL 35 C14H12N2O3 6336-34-1 Details
GR 89696 fumarate C23H29Cl2N3O7 126766-32-3 Details
MYK-461 C15H19N3O2 1642288-47-8 Details
NMDA-IN-1 C20H23ClFN3O 700878-19-9 Details
Chidamide C22H19FN4O2 743420-02-2 Details
5-Carboxamidotryptamine maleate C15H17N3O5 74885-72-6 Details
ITKinhibitor2 C25H33N5O2 1309784-09-5 Details
TOFA C19H32O4 54857-86-2 Details
WT-161 C27H30N4O3 1206731-57-8 Details
PI 828 C19H18N2O3 942289-87-4 Details
TP003 C23H16F3N3O 628690-75-5 Details
Acalabrutinib C26H23N7O2 1420477-60-6 Details
IQ3 C20H11N3O3 312538-03-7 Details
PD 180970 C21H15Cl2FN4O 287204-45-9 Details
Belzutifan C17H12F3NO4S 1672668-24-4 Details
Remimazolam Tosilate C28H27BrN4O5S 1425904-79-5 Details
Lonodelestat C71H111N15O19 906547-89-5 Details
Capmatinib C23H17FN6O 1029712-80-8 Details
Trametinib DMSO solvate C28H29FIN5O5S 1187431-43-1 Details
Dabrafenib Mesylate C24H24F3N5O5S3 1195768-06-9 Details
IEM1754dihydrobroMide C16H32Br2N2 162831-31-4 Details
KIRA6 C28H25F3N6O 1589527-65-0 Details
PA-8 C17H18N4O4 878437-15-1 Details
CNV 1014802 hydrochloride C18H20ClFN2O2 934240-31-0 Details
Silybin A C25H22O10 22888-70-6 Details
Rocatinlimab 2431972-52-8 Details
6-OH-BTA-1 C14H12N2OS 566169-93-5 Details
Mirikizumab 1884201-71-1 Details
Ponatinib Mono-hydrochloride C29H28ClF3N6O 1114544-31-8 Details
Formoterol fumarate dihydrate C23H28N2O8 183814-30-4 Details
TPX-0005 C18H18FN5O2 1802220-02-5 Details
Gilteritinib C29H44N8O3 1254053-43-4 Details
Ponatinib C29H27F3N6O 943319-70-8 Details
Research Grade Sotatercept (DHC33102) 1001080-50-7 Details
Glasdegib C21H22N6O 1095173-27-5 Details
Capmatinib 2HCl C23H18ClFN6O 1197376-85-4 Details
Sotorasib C30H30F2N6O3 2296729-00-3 Details
Lorlatinib C21H19FN6O2 1454846-35-5 Details
GSK 343 C31H39N7O2 1346704-33-3 Details
Fruquintinib|HMPL-013 C21H19N3O5 1194506-26-7 Details
(R)-2-((tert-butoxycarbonyl)amino)-3,3,3-trifluoropropanoic acid C8H12F3NO4 1354225-89-0 Details
Apremilast Impurity 1 C23H26N2O8S 2487573-01-1 Details
(S)-2-((tert-Butoxycarbonyl)amino)-3,3,3-trifluoropropanoic acid C8H12F3NO4 1932644-89-7 Details
(R)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3,3,3-trifluoropropanoicacid C18H14F3NO4 1704706-86-4 Details
Research Grade Spesolimab 2097104-58-8 Details
Futibatinib C22H22N6O3 1448169-71-8 Details
intermediate C19H23NO2 722520-42-5 Details
Brexpiprazole C25H27N3O2S 913611-97-9 Details
2-Fluoro-4-nitrobenzoic acid C7H4FNO4 403-24-7 Details
camlipixant C23H24F2N4O4 1621164-74-6 Details
FAP-2286 C67H99N13O18S3 2581741-18-4 Details
Tislelizumab 1858168-59-8 Details
Baricitinib C16H17N7O2S 1187594-09-7 Details
Leniolisibphosphate C21H28F3N6O6P 1354691-97-6 Details
Pemigatinib C24H27F2N5O4 1513857-77-6 Details
Cabergoline EP Impurity D C23H32N4O 85329-86-8 Details
Cabergoline EP Impurity E C19H22N2O2 86891-16-9 Details
Cabergoline EP Impurity G C22H30N4O 478815-26-8 Details
Cabergoline EP Impurity F C18H20N2O2 86891-15-8 Details
Cabergoline EP Impurity J C23H33N5O2 153415-36-2 Details
Cabergoline EP Impurity B C26H37N5O2 166533-36-4 Details
Cabergoline EP Impurity C C29H42N6O3 126554-50-5 Details
6-ethyl-1,2,3,4-tetrahydroanthraquinone C16H16O2 15547-17-8 Details
Cefepime C19H24N6O5S2 88040-23-7 Details
Ethyl3-oxo-3-(4-nitrophenyl)propanoate C11H11NO5 838-57-3 Details
6-Amino-2-(4-dimethylaminophenyl)benzothiazole C15H15N3S 909191-20-4 Details
Maleimido-mono-amide-DOTA C22H34N6O9 1006711-90-5 Details
Cabergoline EP Impurity A C18H20N2O2 "81409-74-7 Details
6-OH-BTA-0 C13H10N2OS 178804-18-7 Details
2-Ethyl Anthraquinone C16H12O2 84-51-5 Details
Xanthene C13H10O 92-83-1 Details
Ripretinib C24H21BrFN5O2 1442472-39-0 Details
EGFR-IN-7 C32H41BrN9O2P 2267329-76-8 Details
Product Total: Product Page:
7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58